XML 44 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Business Combinations (Tables)
3 Months Ended
Mar. 31, 2019
Business Combinations [Abstract]  
Summary of Component of Merger Consideration The following table summarizes the components of the Merger Consideration:

(In thousands)

 

 

 

 

Cash paid for outstanding Nutrisystem shares (1)

 

$

1,138,143

 

Value of Tivity Health Common Stock issued in the merger (2)

 

 

132,838

 

Value of Nutrisystem stock options (3)

 

 

6,020

 

Value of Tivity Health replacement awards attributable to pre-combination service (4)

 

 

9,107

 

Total Merger Consideration

 

$

1,286,108

 

  

 

 

(1)

Represents the total cash paid to former Nutrisystem stockholders as cash consideration.  This amount is based on the 29,370,594 shares of Nutrisystem common stock issued and outstanding as of Closing and cash consideration of $38.75 per share, plus cash payable in lieu of fractional shares.

 

(2)

Represents the fair value of 6.3 million shares of Tivity Health Common Stock issued for outstanding Nutrisystem shares as stock consideration.  This amount is based on (a) 29,370,594 Nutrisystem common shares issued and outstanding as of Closing, times (b) the Exchange Ratio of 0.2141, times (c) $21.12, which is equal to the volume-weighted averages of the trading price per share of our Common Stock for the five consecutive trading days up to and including March 6, 2019. 

 

(3)

Represents the fair value of the cash consideration paid for the net settlement of approximately 204,000 Nutrisystem stock options vested and outstanding as of the closing date.  In accordance with the Merger Agreement, each vested and outstanding Nutrisystem stock option was cancelled, and the holder received a cash payment per option equal to approximately $43.27 minus the applicable exercise price of the stock option.

 

(4)

Unvested restricted stock awards and performance stock units held by Nutrisystem employees were assumed by Tivity Health and converted into time-vesting restricted stock awards and time-vesting restricted stock units, respectively (“Replacement Awards”).  The value in the table represents the portion of the fair value of the Replacement Awards that relates to pre-combination services.  

Preliminary Allocation of Estimated Merger Consideration to the Identifiable Tangible and Intangible Assets Acquired and Liabilities Assumed We performed a valuation analysis of the fair market value of Nutrisystem’s assets and liabilities as of Closing. The following table sets forth an allocation of the Merger Consideration to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill.  This allocation of the Merger Consideration may be subject to revision if new facts and circumstances arise over the measurement period, which may extend up to one year from Closing.

(In thousands)

 

 

 

 

Cash, cash equivalents, and short-term investments

 

$

81,217

 

Accounts receivable

 

 

22,639

 

Inventory

 

 

38,494

 

Prepaid expenses and other current assets

 

 

12,345

 

Property and equipment

 

 

31,233

 

Right-of-use assets

 

 

22,145

 

Intangible assets

 

 

948,000

 

Other assets/liabilities

 

 

7,161

 

Accounts payable

 

 

(58,253

)

Accrued salaries and benefits and other liabilities

 

 

(8,695

)

Deferred revenue

 

 

(13,339

)

Lease liabilities

 

 

(22,145

)

Deferred tax liabilities, net

 

 

(220,365

)

Total identifiable assets and liabilities acquired

 

$

840,437

 

Goodwill (1)

 

 

445,671

 

Total Merger Consideration

 

$

1,286,108

 

 

 

(1)

Goodwill represents the excess of merger consideration over the preliminary fair value of the underlying assets acquired and liabilities assumed.  Goodwill is attributable to the assembled workforce of experienced personnel at Nutrisystem and synergies expected to be achieved from the combined operations of Tivity Health and Nutrisystem.

Summary of Pro forma Combined Company Results

The following financial information presents the pro forma combined company results as if the acquisition of Nutrisystem had occurred on January 1, 2018:  

 

(In thousands)

 

Three Months Ended March 31,

 

 

 

 

2019

 

 

2018

 

 

Revenue

 

$

347,542

 

 

$

360,860

 

 

Net loss

 

$

(4,635

)

 

$

(29,842

)